Bausch Health Companies BHC
NYSE BHC
$6.84 -0.05 (-0.65%)
At close: Aug 20, 2026 · 2:02 PM UTC

Bausch Health Companies (BHC) Amortization - Intangibles (2009 - 2026)

Bausch Health Companies (BHC) posted Amortization - Intangibles of $225.0 million for Q2 2026, down 6.64% sequentially from $241.0 million in Q1 2026, and down 12.11% YoY from $256.0 million in Q2 2025.

Bausch Health Companies (BHC) Amortization - Intangibles (2009 - 2026) Analysis & Trends

Bausch Health Companies has reported Amortization - Intangibles for 18 years, with the latest figure at $225.0 million in Q2 2026.

  • Quarterly Amortization - Intangibles fell 12.11% year-over-year to $225.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $955.0 million (down 8.61% YoY) and the FY2025 annual result came in at $1.0 billion, down 7.06% from the prior year.
  • Amortization - Intangibles slipped to $225.0 million in Q2 2026 per BHC's latest filing, from $241.0 million in the prior quarter.
  • Over five years, Amortization - Intangibles peaked at $313.0 million in Q4 2022 and troughed at $225.0 million in Q2 2026.
  • A 5-year average of $268.7 million and a median of $269.5 million in 2023 frame the typical range for Amortization - Intangibles.
  • The sharpest annual moves came in 2022 and 2024: Amortization - Intangibles dropped 16.11% in 2022, then advanced 8.3% in 2024.
  • Over 5 years, Amortization - Intangibles stood at $313.0 million in 2022, then declined by 9.9% to $282.0 million in 2023, then declined by 8.16% to $259.0 million in 2024, then declined by 8.88% to $236.0 million in 2025, then dropped by 4.66% to $225.0 million in 2026.
  • According to Business Quant data, Amortization - Intangibles over the past three periods registered $225.0 million, $241.0 million, and $236.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.94 Bn 42.97 Bn -
2 Teva Pharmaceutical Industries 42.95 Bn 39.30 Bn 2.15 Bn
3 Zoetis 31.58 Bn 29.90 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn
5 United Therapeutics 22.16 Bn 19.49 Bn 683.80 Mn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn
7 Neurocrine Biosciences 15.53 Bn 15.14 Bn 935.80 Mn
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.95 Bn -
10 Bausch Health Companies 2.58 Bn 738.25 Mn 2.10 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 225.00 Mn
Mar 31, 2026 241.00 Mn
Dec 31, 2025 236.00 Mn
Sep 30, 2025 253.00 Mn
Jun 30, 2025 256.00 Mn
Mar 31, 2025 256.00 Mn
Dec 31, 2024 259.00 Mn
Sep 30, 2024 274.00 Mn
Jun 30, 2024 270.00 Mn
Mar 31, 2024 274.00 Mn
Dec 31, 2023 282.00 Mn
Sep 30, 2023 253.00 Mn
Jun 30, 2023 269.00 Mn
Mar 31, 2023 273.00 Mn
Dec 31, 2022 313.00 Mn
Sep 30, 2022 290.00 Mn
Jun 30, 2022 302.00 Mn
Mar 31, 2022 310.00 Mn
Dec 31, 2021 320.00 Mn
Sep 30, 2021 338.00 Mn